Literature DB >> 28109332

Structural Characteristics of α-Synuclein Oligomers.

N Cremades1, S W Chen2, C M Dobson2.   

Abstract

Oligomeric forms of amyloid aggregates have been detected in the brains and tissues of patients suffering from neurodegenerative disorders such as Parkinson's disease, and it is widely thought that such species are key pathogenic agents in the development and spreading of the disease; however, the study of these species has been proven to be extremely challenging, primarily as a result of their intrinsically transient nature and high levels of heterogeneity. Identifying the structural nature and the details of the mechanisms of formation and interconversion of individual oligomeric species, particularly those with high toxicity, is of fundamental importance not only for understanding the mechanisms of protein misfolding and amyloid aggregation but also for the identification of diagnostic and therapeutic targets. In this review, we will focus on the current knowledge of the multitude of oligomeric forms of α-synuclein that have been reported to date, with particular emphasis on their structural features and possible relationship to other amyloid species, in order to build a clearer understanding of the types of oligomeric species that accumulate during the aggregation of α-synuclein and to develop a comprehensive picture of the misfolding behavior of the protein.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Amyloid aggregation; Fibril; Interconversion of states; Multiplicity; Oligomer; Protein misfolding pathways; Relationships between amyloid species; Structure

Mesh:

Substances:

Year:  2016        PMID: 28109332     DOI: 10.1016/bs.ircmb.2016.08.010

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  36 in total

1.  Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.

Authors:  Anvesh K R Dasari; Rakez Kayed; Sungsool Wi; Kwang Hun Lim
Journal:  Biochemistry       Date:  2019-06-07       Impact factor: 3.162

Review 2.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

3.  Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.

Authors:  Theodore A Sarafian; Amneh Yacoub; Anastasia Kunz; Burkan Aranki; Grigor Serobyan; Whitaker Cohn; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2019-08-16       Impact factor: 4.164

Review 4.  Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.

Authors:  Fred Yeboah; Tae-Eun Kim; Anke Bill; Ulf Dettmer
Journal:  Neurobiol Dis       Date:  2019-07-24       Impact factor: 5.996

5.  Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE.

Authors:  Jonathan A Fauerbach; Thomas M Jovin
Journal:  Eur Biophys J       Date:  2017-12-18       Impact factor: 1.733

6.  The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.

Authors:  Vanderlei de Araujo Lima; Rodrigo Esquinelato; Phelippe Carmo-Gonçalves; Lucas Alex do Nascimento; Hudson Lee; David Eliezer; Luciana Romão; Cristian Follmer
Journal:  FEBS Lett       Date:  2021-12-29       Impact factor: 4.124

7.  All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species.

Authors:  Aitor Franco; Pablo Gracia; Adai Colom; José D Camino; José Ángel Fernández-Higuero; Natalia Orozco; Alexander Dulebo; Leonor Saiz; Nunilo Cremades; Jose M G Vilar; Adelina Prado; Arturo Muga
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 8.  Multiple system atrophy: experimental models and reality.

Authors:  Cassia Overk; Edward Rockenstein; Elvira Valera; Nadia Stefanova; Gregor Wenning; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2017-10-20       Impact factor: 17.088

9.  Real-Time Characterization of Cell Membrane Disruption by α-Synuclein Oligomers in Live SH-SY5Y Neuroblastoma Cells.

Authors:  Jacob Parres-Gold; Andy Chieng; Stephanie Wong Su; Yixian Wang
Journal:  ACS Chem Neurosci       Date:  2020-08-07       Impact factor: 4.418

Review 10.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.